Search results
H. Michael Shepard. H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin [1]
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
Michael Shepard, MD specializes in orthopaedic surgery. He renders the most comprehensive care for knee, elbow and shoulder injuries. Dr. Shepard uses the latest medical technology with the state of art medical facility to provide his patients the best possible outcome. Elbow. Jose Alvarez, Pitcher, Los Angeles Angels, MLB – spring training 2018
The 2019 Lasker~DeBakey Clinical Medical Research Award honors three scientists—H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich —who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and developed it into a life-saving therapy for women with breast cancer. The innovation reduces the risk of recurrence and extends survival time for patients with metastatic as well as early-stage disease.
Nov 30, 2021 · EUGENE, Ore., Nov. 30, 2021 /PRNewswire/ -- Dr. Michael Shepard, President and Chief Scientific Officer of Enosi Life Sciences, a drug research and development company focused on providing ...
Dr. Michael Shepard is a board certified Orthopedic Surgeon who is subspecialty trained in sports medicine with special emphasis on the care of the overhead athlete. Dr. Dr. Shepard’s clinical expertise includes elbow and shoulder injuries of the overhead athlete, elbow arthroscopy , and complex knee reconstruction.
Sep 24, 2019 · Dr. H. Michael Shepard and his team recently won the 2019 Lasker Award which is considered by many to be on par with the Nobel Prize. Shepard is a cancer biologist. Shepard is a cancer biologist.
